Exact Mass: 319.0336828
Exact Mass Matches: 319.0336828
Found 167 metabolites which its exact mass value is equals to given mass value 319.0336828
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Gluconyl ethanolamine phosphate
N-Gluconyl ethanolamine phosphate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
ONO-2235; ONO 2235; ONO2235; Sorbistat
2-Chloro-N-[(Z)-[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]benzamide
C15H14ClN3O3 (319.07236439999997)
Sarmazenil
C15H14ClN3O3 (319.07236439999997)
2-(tert-Butylsulfonyl)-3-(3-methylbenzo[b]thiophen-2-yl)acrylonitrile
C16H17NO2S2 (319.07006620000004)
2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide
Hernandonine
An oxoaporphine alkaloid isolated from Hernandia ovigera and Lindera chunii and has been shown exhibit inhibitory activity against HIV-1 integrase .
Cassameridine
An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one which is substituted by methylenedioxy grups at the 1,2 and 9,10 positions. Compared with liriodenine, which lacks the 9,10-methylenedioxy group, cassameridine displays only moderate antifungal activity.
Epalrestat
C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors
N-Gluconyl ethanolamine phosphate
(R)-2-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid
Cetophenicol
C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
3-bromo-4-[(4-methylphenyl)methylamino]benzoic acid
Methyl 5,5,5-trifluoro-4-(2-(4-nitrophenyl) hydrazono)pentanoate
C12H12F3N3O4 (319.07798679999996)
(S)-2-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
1-(PHENYLSULFONYL)-1H-INDOLE-2-CARBONYL CHLORIDE
C15H10ClNO3S (319.00699000000003)
3-[4-(METHOXYCARBONYL)PHENYL]-3-[(2,2,2-TRIFLUOROACETYL)AMINO]PROPANOIC ACID
C13H12F3NO5 (319.06675379999996)
2-[(3-BROMOANILINO)CARBONYL]-BENZOIC ACID
C14H10BrNO3 (318.98440100000005)
2-[(4-BROMOANILINO)CARBONYL]-BENZOIC ACID
C14H10BrNO3 (318.98440100000005)
1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride
2-methyl-3-sulfobutyl-5-chlorobenzothiazolium, inner salt
2-(2-(4-BROMO-1H-PYRAZOL-1-YL)ETHYL)ISOINDOLINE-1,3-DIONE
6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
C16H8F3NO3 (319.04562540000006)
2-[(4-bromobenzoyl)amino]benzoic acid
C14H10BrNO3 (318.98440100000005)
2-amino-2-(3,4-dichlorophenyl)-3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoic acid
2,6-dimethyl-3-ethylbenzothiazolium iodide
C11H14INS (318.98916740000004)
2-[(2-bromobenzoyl)amino]benzoic acid
C14H10BrNO3 (318.98440100000005)
METHYL2-(PIPERIDIN-4-YLSULFONYL)BENZOATEHYDROCHLORIDE
Bupropion hydrobromide
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one
2-[[(2-BROMOPHENYL)AMINO]CARBONYL]-BENZOIC ACID
C14H10BrNO3 (318.98440100000005)
1-[(4-Bromophenyl)sulfonyl]-4-piperidinol
C11H14BrNO3S (318.98777140000004)
Astat
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives C254 - Anti-Infective Agent > C514 - Antifungal Agent
1-[(5-Bromo-2-methoxyphenyl)sulfonyl]pyrrolidine
C11H14BrNO3S (318.98777140000004)
3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile
C15H8F3N3S (319.03910040000005)
5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE
C13H14BrN5 (319.04325040000003)
5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE
C13H14BrN5 (319.04325040000003)
4-(4-Bromophenyl)piperidine-4-carboxylic acid hydrochloride
C12H15BrClNO2 (318.99746200000004)
3-FLUORO-5-(5-((2-METHYLTHIAZOL-4-YL)ETHYNYL)PYRIDIN-2-YL)BENZONITRILE
C18H10FN3S (319.05794320000007)
4-((4-Bromo-3-methylphenyl)sulfonyl)morpholine
C11H14BrNO3S (318.98777140000004)
7-(1,3-Benzothiazol-2-yl)-6-hydroxy-4-oxo-1,4-dihydro-3-quinoline carbonitrile
5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde
C14H7F6NO (319.04318040000004)
ETHYL1-(4-BROMOPHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLATE
(S)-2-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
N-(4-Chlorobenzoyloxy)-4-nitrobenzimidamide
4-[4-(bromomethyl)phenyl]sulfonylmorpholine
C11H14BrNO3S (318.98777140000004)
4-Chloro-6-(trifluoromethoxy)quinoline-3-carboxylic acid ethyl ester
C13H9ClF3NO3 (319.02230299999997)
1-(3-Bromophenyl)-2-[(2-methyl-2-propanyl)amino]-1-propanone hydr ochloride (1:1)
METHYL 2-([(4-CHLOROPHENYL)SULFONYL]AMINO)-4-METHYLPENTANOATE
1-(3-bromo-4-methylphenylsulfonyl)morpholine
C11H14BrNO3S (318.98777140000004)
Sarmazenil
C15H14ClN3O3 (319.07236439999997)
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
4-((2-(Bromomethyl)phenyl)sulfonyl)morpholine
C11H14BrNO3S (318.98777140000004)
ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-8-(PROP-2-YNYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE
(R)-2-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
1-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dimethylmethanamine
4-(6-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
(2S,4R)-4-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(2S,4R)-4-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(2S,4R)-4-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(S)-2-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
(R)-2-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
C12H15BrClNO2 (318.99746200000004)
Thiazolidine, 2-(4-methylphenyl)-3-(phenylsulfonyl)- (9CI)
C16H17NO2S2 (319.07006620000004)
3-(5,6-dichloro-1-methylindol-2-yl)benzoic acid
C16H11Cl2NO2 (319.01668060000003)
4-(2-(2-BROMO-5-CHLOROPHENOXY)ETHYL)MORPHOLINE
C12H15BrClNO2 (318.99746200000004)
1-[(3-Bromophenyl)sulfonyl]-4-piperidinol
C11H14BrNO3S (318.98777140000004)
1-(benzenesulfonyl)indole-3-carbonyl chloride
C15H10ClNO3S (319.00699000000003)
n-(2-(4-bromophenoxy)ethyl)piperidine hydrochloride
4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline
4-(chloromethyl)-2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazole hydrochloride
2-Propanesulfinamide, N-[1-(5-bromo-2-fluorophenyl)ethylidene]-2-methyl-, [N(E),S(S)]-
C12H15BrFNOS (319.00416920000004)
1-Oxa-8-azaspiro[4,5]decane-8-carboxylic acid,3-bromo-,1,1-dimethylethylester
C13H22BrNO3 (319.07829620000007)
FAAH-IN-2
FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.
2-METHYL-3-PROPYLBENZOTHIAZOLIUM IODIDE
C11H14INS (318.98916740000004)
1-[(3-Bromo-4-methoxyphenyl)sulfonyl]pyrrolidine
C11H14BrNO3S (318.98777140000004)
tert-Butyl 5-chloro-6-(trifluoromethyl)-1H-indole-1-carboxylate
6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetamide
C15H11Cl2N3O (319.02791360000003)
4-Pyrimidinamine, 5-bromo-N-cyclopentyl-2-(Methylsulfonyl)-
C10H14BrN3O2S (318.99900440000005)
1-(4-Nitrophenyl)-5-(trifluoromethyl)pyrazole-4-carbonyl chloride
C11H5ClF3N3O3 (318.99715260000005)
(1R)-1-(2-Thienylacetylamino)-1-(3-carboxyphenyl)methylboronic acid
C14H14BNO5S (319.06857040000006)
2-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
2-Hydroxy-4-methylbenzoic acid [2-(2-chloroanilino)-2-oxoethyl] ester
4-fluoro-N-(4-fluoro-1,3-benzothiazol-2-yl)-1,3-benzothiazol-2-amine
N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide
C18H13N3OS (319.07792880000005)
N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide
3,4-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate
Benzene, 1,2,3,4,5-pentafluoro-6-((4-nitrophenoxy)methyl)-
C13H6F5NO3 (319.02678260000005)
3,4,8,9,10-Pentahydroxy-6-oxobenzo[c]chromene-1-carboxylate
-[(1R,3S)-5,6,9,10-tetrahydroxy-1-methyl-1H,3H,4H-naphtho[2,3-c]pyran-3-yl]acetate
(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate
2-Chloro-N-[(Z)-[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]benzamide
C15H14ClN3O3 (319.07236439999997)
4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide
C15H14ClN3O3 (319.07236439999997)
N-[[[(4-methoxyphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide
N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide
6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole
N-[(1,3-dimethyl-4,6-dioxo-2-thioxotetrahydropyrimidin-5(2H)-ylidene)methyl]pyridine-4-carbohydrazide
C13H13N5O3S (319.07390680000003)
3-[[(3-Chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid
[3-(4-Chlorophenyl)-5-(methylthio)-1,2,4-triazol-1-yl]-(2-furanyl)methanone
C14H10ClN3O2S (319.01822300000003)
(4-Bromo-2,5-dimethyl-3-pyrazolyl)-(2,3-dihydroindol-1-yl)methanone
C14H14BrN3O (319.03201740000003)
1-(2-Methylprop-2-enyl)-3-[(5-nitro-2-oxo-3-indolyl)amino]thiourea
C13H13N5O3S (319.07390680000003)
N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide
C11H14ClN3O4S (319.03935140000004)
6,7-dimethoxy-2-[(1H-1,2,4-triazol-5-ylthio)methyl]-1H-quinazolin-4-one
C13H13N5O3S (319.07390680000003)
N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide
(E)-3-(5-bromofuran-2-yl)-N-[(4-methylphenyl)methyl]prop-2-enamide
1-[[2-(3,4-Dichlorophenyl)acetyl]amino]-3-propylthiourea
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-N-sulfooxymethanimidothioate
(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide
N-(2,4-Dichloro-5-(2-hydroxyethoxy)phenoxycarbonyl)tetrahydropyrrole
4-(3,5-Dichloro-4-hydroxyphenylimino)tetralin-1-one
C16H11Cl2NO2 (319.01668060000003)
{4-[(1e)-2-{[bis(methylsulfanyl)methylidene]amino}ethenyl]phenyl}oxidanesulfonic acid
(2r)-2-hydroxy-3-{[(2s)-3-methoxy-2-[(3r)-3-methyl-2,5-dioxopyrrolidin-1-yl]-3-oxopropyl]sulfanyl}propanoic acid
C12H17NO7S (319.07256920000003)
2-hydroxy-3-{[3-methoxy-2-(3-methyl-2,5-dioxopyrrolidin-1-yl)-3-oxopropyl]sulfanyl}propanoic acid
C12H17NO7S (319.07256920000003)